These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9589875)

  • 1. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases].
    Shimizu N; Yamanaka H; Ichinose Y; Saitou Y
    Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
    Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.
    Okihara K; Kitamura K; Okada K; Mikami K; Ukimura O; Miki T
    Int J Urol; 2008 Feb; 15(2):156-60; discussion 161. PubMed ID: 18269453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate cancer screening in total health care check--using serum PSA and AUA score].
    Komeda Y; Soga N; Sato Y; Sato K; Suzuki R; Kawamura J
    Hinyokika Kiyo; 1996 Apr; 42(4):275-8. PubMed ID: 8693959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A mass screening of the prostatic diseases and serum prostate specific antigen].
    Kato M; Okada K
    Hinyokika Kiyo; 1991 Aug; 37(8):887-90. PubMed ID: 1720276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
    Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine].
    Bourel M; Ardaillou R;
    Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
    Roobol MJ; Grenabo A; Schröder FH; Hugosson J
    J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass screening for prostate cancer in Japan].
    Akimoto S; Ichikawa T; Shimazaki J
    Nihon Rinsho; 1996 May; 54(5):1447-51. PubMed ID: 8965383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advancements in PSA-based screening for prostate cancer].
    Ito K
    Rinsho Byori; 2004 Jul; 52(7):611-7. PubMed ID: 15344561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long follow-up on prostate specific antigen density and prostate biopsy.
    Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
    Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mass screening for prostate cancer at a local town--five-year results and screening system].
    Komeda Y; Suzuki R; Maeda Y; Okabe S; Kawamura J; Hioki T; Ohawa M
    Hinyokika Kiyo; 1994 Apr; 40(4):315-8. PubMed ID: 7514844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
    Roobol MJ; Kranse R; de Koning HJ; Schröder FH
    Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.